Seeking to accelerate technological capabilities, healthcare investors have been snapping up AI and machine learning companies and driving up digital health M&A in the pharmaceutical and biotechnology space as a result.

This continues a trend as the Amsterdam-based company looks to lend more stability and predictability to the acquisition of new diagnostic technology.

Life expectancy in the U.S. is lagging far behind that of other developed nations, according to a review published in the Journal of the American Medical Association—a phenomenon driven by an increase in drug overdoses, suicides and organ system diseases like CVD.

Five radiology groups and departments were awarded trophies at RSNA 2019 in Chicago last week for combining creative thinking with coordinated teamwork to develop an original breakthrough in medical imaging.

That’s according to a bombshell new report from the VA Office of the Inspector General, released on Tuesday., Oct. 10. 

Harrison.ai, a Sydney, Australia-based healthcare company focused on AI technologies, has raised $19.9 million (A$29 million) in funding.

The widow of a 48-year-old man was awarded $6.3 million this week after her husband, who’d been cleared of CVD by his cardiologist six weeks before his death, suffered a fatal heart attack while jogging.

AI’s impact on medical imaging continues to be one of the most significant trends of the last several years, and now the FDA has announced a public workshop focused on that very subject.